23 results
DEF 14A
CMRA
Comera Life Sciences Holdings, Inc.
11 Aug 23
Definitive proxy
4:15pm
Committee Interlocks and Insider Participation
Code of Business Conduct and Ethics
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Equity … or employee of our company, nor has any of them ever been an officer or employee of our company.
Code of Business Conduct and Ethics
We have adopted
PRE 14A
CMRA
Comera Life Sciences Holdings, Inc.
1 Aug 23
Preliminary proxy
5:08pm
Oversight
Compensation Committee Interlocks and Insider Participation
Code of Business Conduct and Ethics
Equity Financings
Legacy Comera Stockholder … Conduct and Ethics
We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
authorities, IRBs, or independent ethics committees at the institutions in which our trials are conducted, could suspend, limit or terminate our clinical … studies or clinical trials or to delay or terminate a clinical trial;
regulators or IRBs or ethics committees may delay or may not authorize us
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
, or independent ethics committees at the institutions in which our trials are conducted, could suspend, limit or terminate our clinical trials … trials or to delay or terminate a clinical trial;
regulators or IRBs or ethics committees may delay or may not authorize us or our investigators
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:32pm
, IRBs, or independent ethics committees at the institutions in which our trials are conducted, could suspend, limit or terminate our clinical trials … studies or clinical trials or to delay or terminate a clinical trial;
regulators or IRBs or ethics committees may delay or may not authorize us or our
424B3
yebl5
14 Nov 22
Prospectus supplement
5:19pm
424B3
03d2eu0kxm
14 Nov 22
Prospectus supplement
5:15pm
424B3
9gezjrzsu0
14 Nov 22
Prospectus supplement
5:09pm
424B3
o5j0em0gv1ipr63hsw
14 Nov 22
Prospectus supplement
4:50pm
424B3
h9zt7 j6k9heoog
15 Sep 22
Prospectus supplement
4:09pm
424B3
yjto0
15 Aug 22
Prospectus supplement
5:45pm
10-Q
9oljilvo2oy734cq
15 Aug 22
Quarterly report
4:53pm
424B3
ztgv 0hwb
28 Jun 22
Prospectus supplement
10:45am
S-1
f3o6 qv6qwa
4 May 22
IPO registration
9:23pm
424B3
30x jko85h65cit6ej
15 Apr 22
Prospectus supplement
11:45am